Vycor Medical, Inc. (VYCO)

OTCMKTS · Delayed Price · Currency is USD

0.0690

-0.0010 (-1.43%)

May 28, 2026, 3:38 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Vycor Medical	1.80M	1.52M	1.38M	1.13M	1.27M
Vycor Medical Growth	18.49%	9.95%	21.90%	-11.20%	22.51%
NovaVision	67.33K	73.58K	82.01K	92.07K	119.39K
NovaVision Growth	-8.49%	-10.27%	-10.93%	-22.88%	16.49%
Total	1.86M	1.59M	1.46M	1.22M	1.39M
Total Growth	17.24%	8.81%	19.43%	-12.20%	21.97%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	1.86M	1.59M	1.45M	1.21M	1.37M
United States Growth	17.21%	9.06%	19.69%	-11.64%	22.18%
Europe	4.91K	3.68K	6.71K	8.27K	18.22K
Europe Growth	33.32%	-45.15%	-18.84%	-54.62%	8.31%
Total	1.86M	1.59M	1.46M	1.22M	1.39M
Total Growth	17.24%	8.81%	19.43%	-12.20%	21.97%

Source: S&P Global Market Intelligence.